Human liver-type fatty acid-binding protein protects against tubulointerstitial injury in aldosterone-induced renal injury.
Daisuke Ichikawa, Atsuko Kamijo-Ikemori, Takeshi Sugaya, Yugo Shibagaki, Takashi Yasuda, Seiko Hoshino, Kimie Katayama, Junko Igarashi-Migitaka, Kazuaki Hirata, Kenjiro Kimura
Index: Am. J. Physiol. Renal Physiol. 308(2) , F114-21, (2015)
Full Text: HTML
Abstract
To demonstrate the renoprotective function of human liver-type fatty acid-binding protein (hL-FABP) expressed in proximal tubules in aldosterone (Aldo)-induced renal injury, hL-FABP chromosomal transgenic (Tg) and wild-type (WT) mice received systemic Aldo infusions (Tg-Aldo and WT-Aldo, respectively) were given 1% NaCl water for 28 days. In this model, elevation of systolic blood pressure, monocyte chemoattractant protein-1 expression, macrophage infiltration in the interstitium, tubulointerstitial damage, and depositions of type I and III collagens were observed. Elevation of systolic blood pressure did not differ in WT-Aldo vs. Tg-Aldo animals, however, renal injury was suppressed in Tg-Aldo compared with WT-Aldo mice. Dihydroethidium fluorescence was used to evaluate reactive oxidative stress, which was suppressed in Tg-Aldo compared with WT-Aldo mice. Gene expression of angiotensinogen in the kidney was upregulated, and excretion of urinary angiotensinogen was increased in WT-Aldo mice. This exacerbation was suppressed in Tg-Aldo mice. Expression of hL-FABP was upregulated in proximal tubules of Tg-Aldo mice. Urinary excretion of hL-FABP was significantly greater in Tg-Aldo than in Tg-control mice. In conclusion, hL-FABP ameliorated the tubulointerstitial damage in Aldo-induced renal injury via reducing oxidative stress and suppressing activation of the intrarenal renin-angiotensin system. Copyright © 2015 the American Physiological Society.
Related Compounds
Related Articles:
2014-02-01
[Hypertension 63(2) , 281-8, (2014)]
2013-10-01
[J. Surg. Res. 184(2) , 861-6, (2013)]
2013-04-01
[J. Mol. Endocrinol. 50(2) , R53-66, (2013)]
2013-12-01
[Hum. Pathol. 44(12) , 2806-13, (2013)]
2013-01-01
[BMC Cardiovasc. Disord. 13 , 17, (2013)]